Initially the jada was working and controlling the bleeding, but then it clotted off [device occlusion].Did a d&c on the pateint but the patient continued to bleed [device ineffective].Removed the jada, did another manual sweep of the patient, and then tried to replace the jada [device use error].Case narrative: this initial spontaneous report originating from the united states, was received from a physician and nurse via clinical account specialist referring to a 22-year-old female patient.The patient¿s current conditions included uterine atony.The patient¿s historical conditions included singleton pregnancy, bleeding, cesarean, fetal demise, and blood products transfusion (unknown volume).The patient¿s concomitant medications were not reported.This report concerned 1 patient and 1 device.On an unknown date in (b)(6) 2023 (reported as 1-2 weeks ago), the patient was started on vacuum-induced hemorrhage control system (jada system) (lot# and expiry date were not reported) (came with blue seal valve, kit and green carton) vaginally as directed by the health care professional (hcp) for postpartum hemorrhage (postpartum haemorrhage).Initially the vacuum-induced hemorrhage control system (jada system) was worked and controlled the bleeding, but then it clotted off (also reported as initially it worked and the uterine tone was slightly improved but then it clotted off) (device occlusion).The physician removed the vacuum-induced hemorrhage control system (jada system) and did another manual sweep of the patient, and then tried to replace the vacuum-induced hemorrhage control system (jada system) but it immediately clogged off again (device use error).Then the physician did dilation and curettage (d&c) on the patient, but the patient continued to bleed (device ineffective).The device was operated by fellow, maternal fetal medicine and it may be first time for the operator.The physician tried placing another vacuum-induced hemorrhage control system (jada system), but it also clotted off (also reported that the second one was used as the first one clotted off and was no longer sterile) (captured in oars# (b)(4)).The patient then underwent hysterectomy and bleeding was controlled.The patient sought medical attention.Therapy with vacuum-induced hemorrhage control system (jada system) was discontinued.The availability of the vacuum-induced hemorrhage control system (jada system) for evaluation was unknown.Upon internal review, the event of device occlusion and device ineffective was determined to be serious: required intervention.This is one of the two reports received from the same reporter.Medical device reporting criteria: serious injury.Fda code: (health effects - health impact per annex f): 4648 insufficient information (there is not yet enough information available to classify the health impact.).Fda code: (health effects - health impact per annex f): 4624 surgical intervention (one or more surgical procedures was required, or an existing procedure changed.).
|